Navigation Links
Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
Date:8/10/2011

NEW YORK, Aug. 10, 2011 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) announced today that management will present at the Wedbush 2011 Life Sciences Management Access Conference on Tuesday, August 16, 2011 at 2:25 P.M. ET in New York.  David McDonald, Chief Financial Officer, will provide an overview of the Company's business strategy and recent corporate developments.

Attendance at this conference is by invitation only. Delcath will offer a live audio webcast of its presentation, which may be accessed on the Investor Relations section of the Company's website at www.delcath.com.  An archived replay of the presentation will be available for 90 days, also at www.delcath.com.

About Delcath SystemsDelcath Systems, Inc. is a development stage specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase III metastatic melanoma study, and the Company recently completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Hepatic CHEMOSAT delivery system in April 2011. The Company has not yet received FDA approval for commercial sale of its system in the United States. For more information, please visit the Company's website at http://www.delcath.com/.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news re
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
2. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
3. Delcath Systems, Inc. Announces the Sale of 5,000,000 Shares of Common Stock
4. Delcath on Preliminary List of Additions to Russell Microcap® Index
5. Delcath to Present at the JMP Securities Research Conference
6. Delcath Names Harold C. Mapes as Executive Vice President of Global Operations
7. Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSAT™ Delivery System
8. Delcath to Update Investors on FDA Meeting
9. Delcath Expands Board of Directors With Appointment of Gabriel Leung
10. Delcath to Present at Upcoming Investor Conferences
11. Delcath Systems Receives Refusal to File Letter From FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) ... support, China,s orthopedic instrument industry ... market size rising from 3.28 billion yuan in 2006 ...
(Date:1/15/2014)... Foundation today announced it has established a relief fund ... weather that has gripped much of the nation. AARP and ... to support these emergency relief efforts AARP and AARP Foundation ... up to $500,000 in aid. The matching program will be ...
(Date:1/15/2014)... plc (LSE: SHP, NASDAQ: SHPG ) announces that it ... the announced tender offer for all of the outstanding shares of ... the waiver, the transaction is no longer conditional on OFT approval, ... 2014 following the currently scheduled expiration time, subject to the satisfaction ...
Breaking Medicine Technology:Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
(Date:4/24/2014)... of three survivors of critical illness, according to ... Respiratory Medicine , and the majority of patients ... It is one of the largest studies to ... critical care survivors, according to lead author James ... highlights a significant public health issue, with roughly ...
(Date:4/24/2014)... A Finnish team of researchers was the first in ... which is a tumour of the jaw. , Ameloblastoma ... recur after treatment. Ameloblastoma is most often found in ... by surgery, often resulting in tissue deficiencies in the ... suitable drug therapy could reduce the need for surgery ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
(Date:4/24/2014)... 2009 the influenza pH1N1 virus caused the first flu ... in May 2009 and killed more than 50 people ... Finns mainly during flu epidemics (winter/spring seasons). , ... serious complicated illnesses. World Health Organization has recommended Tamiflu ... The disadvantage of this drug is that it targets ...
(Date:4/23/2014)... (MGH) investigators may lead to greater availability and acceptability ... use of fecal material from healthy donors to ... ( C. difficile ) bacteria. In their ... Infectious Diseases , the researchers report that use of ... was as successful in curing recurrent C. difficile ...
Breaking Medicine News(10 mins):Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3
... Company-Sponsored "Technology Topics" Workshop Scheduled for 1 to ... Regency Century Plaza, Constellation Room A., WELLESLEY, ... in,the development of cost-effective, easy-to-use gene-expression analysis,systems, announced ... System for research use only at the Association ...
... Code Created for Minimally Invasive Procedure to Treat ... ... Endocare, Inc.,(Nasdaq: ENDO ), an innovative medical device company focused ... that the Centers for Medicare and Medicaid Services,(CMS) have accepted the ...
... Anke Linnartz (38) is,to assume responsibility for managing ... 1, 2008. In this position she will report ... supplier of high-quality packaging solutions based on glass,and ... has been,listed on the Frankfurt stock exchange since ...
... well known risk factor for prostate, breast and colon ... responsible for generating fat cells also plays an important ... Singapore have conducted, for the first time, a genome-wide ... gamma (PPARg), turns on various genes related to obesity. ...
... - Total revenue grew 35% to $63.7 ... 11 consecutive annual cycles - ... earnings per share of $0.27 in line with guidance, TUCSON, Ariz., Nov. ... for the third,quarter ended September 30, 2007. For the third quarter of ...
... recognition of,Alzheimer,s Awareness Month, The HealthCentral Network,s,( ... to encourage early detection and a better ... who suffer from the condition or,are caring ... The special Alzheimer,s Awareness online feature,( ...
Cached Medicine News:Health News:Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85 2Health News:Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85 3Health News:Medicare Sets Physician Payment Rate for Percutaneous Kidney Cryoablation 2Health News:Medicare Sets Physician Payment Rate for Percutaneous Kidney Cryoablation 3Health News:Researchers chart the genetic mechanisms behind the genesis of fat cells 2Health News:Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007 2Health News:Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007 3Health News:Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007 4Health News:Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007 5Health News:Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007 6Health News:Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007 7Health News:Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007 8Health News:Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007 9Health News:Providence Service Corporation Announces 35% Revenue Growth with Third Quarter Results; Increases Revenue Guidance for 2007 10Health News:The HealthCentral Network Honors Alzheimer's Awareness Month 2
Semkin forceps with stops. Insulated....
Scoville-Greenwood bayonet forceps...
Angled 60 degree blades 5.5 mm....
... Accurately tests for Nystagmus when rotated ... high by 8" diameter. Light weight ... bearings for effortless spin mechanism. For ... patient. Includes both Adult and Pediatric ...
Medicine Products: